(Q48149688)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14607509%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

title

Microspheres containing insulin-like growth factor I for treatment of chronic neurodegeneration (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14607509%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

1 reference

1 reference

1 reference

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14607509%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Ignacio Torres Aleman

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14607509%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

author name string

C Carrascosa

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14607509%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

C Lopez-Lopez

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14607509%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

L Espejo

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14607509%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

S Torrado

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14607509%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

J J Torrado

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14607509%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

publication date

1 February 2004

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14607509%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14607509%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

volume

25

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14607509%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14607509%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

page(s)

707-714

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14607509%20AND%20SRC:MED&resulttype=core&format=json

Neurotrophins: from enthusiastic expectations through sobering experiences to rational therapeutic approaches

20 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0142-9612%2803%2900562-3

7 January 2021

Drug and gene delivery to the brain: the vascular route

1 reference

https://api.crossref.org/works/10.1016%2FS0142-9612%2803%2900562-3

7 January 2021

Insulin-like growth factor I restores motor coordination in a rat model of cerebellar ataxia

1 reference

https://api.crossref.org/works/10.1016%2FS0142-9612%2803%2900562-3

7 January 2021

Continuous versus intermittent subcutaneous infusion of octreotide in the treatment of acromegaly

1 reference

https://api.crossref.org/works/10.1016%2FS0142-9612%2803%2900562-3

7 January 2021

Sustained release of recombinant human insulin-like growth factor-I for treatment of diabetes.

1 reference

https://api.crossref.org/works/10.1016%2FS0142-9612%2803%2900562-3

7 January 2021

Stabilizing insulin-like growth factor-I in poly(D,L-lactide-co-glycolide) microspheres

1 reference

https://api.crossref.org/works/10.1016%2FS0142-9612%2803%2900562-3

7 January 2021

Controlled release of recombinant insulin-like growth factor from a novel formulation of polylactide-co-glycolide microparticles

1 reference

https://api.crossref.org/works/10.1016%2FS0142-9612%2803%2900562-3

7 January 2021

Aging as a major risk for degenerative diseases of the central nervous system.

1 reference

https://api.crossref.org/works/10.1016%2FS0142-9612%2803%2900562-3

7 January 2021

Circulating insulin-like growth factor I mediates the protective effects of physical exercise against brain insults of different etiology and anatomy.

1 reference

https://api.crossref.org/works/10.1016%2FS0142-9612%2803%2900562-3

7 January 2021

Kinetic analysis of the disposition of insulin-like growth factor 1 in healthy volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS0142-9612%2803%2900562-3

7 January 2021

The effect of the frequency of subcutaneous insulin-like growth factor-1 administration on weight gain in growth hormone deficient mice

1 reference

https://api.crossref.org/works/10.1016%2FS0142-9612%2803%2900562-3

7 January 2021

Alteration of IGF system gene expression during the postnatal development of pcd mice

1 reference

https://api.crossref.org/works/10.1016%2FS0142-9612%2803%2900562-3

7 January 2021

Neurotrophic factor therapy for nervous system degenerative diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0142-9612%2803%2900562-3

7 January 2021

Insulin-like growth factors I and II. Peptide, messenger ribonucleic acid and gene structures, serum, and tissue concentrations

1 reference

https://api.crossref.org/works/10.1016%2FS0142-9612%2803%2900562-3

7 January 2021

https://api.crossref.org/works/10.1016%2FS0142-9612%2803%2900562-3

1 reference

7 January 2021

Serum growth factors and neuroprotective surveillance: focus on IGF-1.

1 reference

https://api.crossref.org/works/10.1016%2FS0142-9612%2803%2900562-3

7 January 2021

Circulating insulin-like growth factor I mediates effects of exercise on the brain.

1 reference

https://api.crossref.org/works/10.1016%2FS0142-9612%2803%2900562-3

7 January 2021

Pharmacokinetics of recombinant human insulin-like growth factor I given subcutaneously to healthy volunteers and to patients with growth hormone receptor deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0142-9612%2803%2900562-3

7 January 2021

Effects of insulin-like growth factor on weight gain in chronic hypoxic rats

1 reference

https://api.crossref.org/works/10.1016%2FS0142-9612%2803%2900562-3

7 January 2021

Effect of recombinant human insulin-like growth factor-I on progression of ALS. A placebo-controlled study. The North America ALS/IGF-I Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0142-9612%2803%2900562-3

7 January 2021

Neurodegeneration is associated to changes in serum insulin-like growth factors.

1 reference

https://api.crossref.org/works/10.1016%2FS0142-9612%2803%2900562-3

7 January 2021

Plasma insulin-like growth factor I and IGF binding protein 3 levels in patients with acute cerebral ischemic injury

1 reference

https://api.crossref.org/works/10.1016%2FS0142-9612%2803%2900562-3

7 January 2021

Insulin-like growth factors and insulin-like growth factor binding proteins in cerebrospinal fluid and serum of patients with dementia of the Alzheimer type.

1 reference

https://api.crossref.org/works/10.1016%2FS0142-9612%2803%2900562-3

7 January 2021

Low levels of insulin-like growth factor-I in cerebrospinal fluid in children with autism.

1 reference

https://api.crossref.org/works/10.1016%2FS0142-9612%2803%2900562-3

7 January 2021

Pharmacological characteristics of parenteral IGF-I administration

1 reference

https://api.crossref.org/works/10.1016%2FS0142-9612%2803%2900562-3

7 January 2021

The insulin-like growth factor I system in cerebellar degeneration.

1 reference

https://api.crossref.org/works/10.1016%2FS0142-9612%2803%2900562-3

7 January 2021

Macromolecular permeability across the blood-nerve and blood-brain barriers

1 reference

https://api.crossref.org/works/10.1016%2FS0142-9612%2803%2900562-3

7 January 2021

Solvent effects on the solubility and physical stability of human insulin-like growth factor I

1 reference

https://api.crossref.org/works/10.1016%2FS0142-9612%2803%2900562-3

7 January 2021

Investigation of protein/carbohydrate interactions in the dried state. 2. Diffuse reflectance FTIR studies.

1 reference

https://api.crossref.org/works/10.1016%2FS0142-9612%2803%2900562-3

7 January 2021